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Abstract
Background: Glucose is the most important metabolic substrate of the retina and maintenance of normoglycemia is an
essential challenge for diabetic patients. Glycemic excursions could lead to cardiovascular disease, nephropathy,
neuropathy and retinopathy. A vast body of literature exists on hyperglycemia namely in the field of diabetic retinopathy,
but very little is known about the deleterious effect of hypoglycemia. Therefore, we decided to study the role of acute
hypoglycemia in mouse retina.
Methodology/Principal Findings: To test effects of hypoglycemia, we performed a 5-hour hyperinsulinemic/hypoglycemic
clamp; to exclude an effect of insulin, we made a hyperinsulinemic/euglycemic clamp as control. We then isolated retinas
from each group at different time-points after the clamp to analyze cells apoptosis and genes regulation. In parallel, we
used 661W photoreceptor cells to confirm in vivo results. We showed herein that hypoglycemia induced retinal cell death in
mouse via caspase 3 activation. We then tested the mRNA expression of glutathione transferase omega 1 (Gsto1) and
glutathione peroxidase 3 (Gpx3), two genes involved in glutathione (GSH) homeostasis. The expression of both genes was
up-regulated by low glucose, leading to a decrease of reduced glutathione (GSH). In vitro experiments confirmed the low-
glucose induction of 661W cell death via superoxide production and activation of caspase 3, which was concomitant with a
decrease of GSH content. Moreover, decrease of GSH content by inhibition with buthionine sulphoximine (BSO) at high
glucose induced apoptosis, while complementation with extracellular glutathione ethyl ester (GSHee) at low glucose
restored GSH level and reduced apoptosis.
Conclusions/Significance: We showed, for the first time, that acute insulin-induced hypoglycemia leads to caspase 3-
dependant retinal cell death with a predominant role of GSH content.
Citation: Emery M, Schorderet DF, Roduit R (2011) Acute Hypoglycemia Induces Retinal Cell Death in Mouse. PLoS ONE 6(6): e21586. doi:10.1371/
journal.pone.0021586
Editor: Bob Lightowlers, Newcastle University, United Kingdom
Received December 22, 2010; Accepted June 6, 2011; Published June 27, 2011
Copyright:  2011 Emery et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The authors have no support or funding to report.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: raphael.roduit@irovision.ch
Introduction
Neural tissue, including retina, is totally dependent on glucose
for normal metabolic activity. Since the level of glucose storage is
negligible compared with the eye glucose demand, this tissue is
dependent on glucose delivery by circulating blood. In both type I
and II diabetes, normalization of blood glucose concentration is an
important issue to avoid secondary long-term microvascular
complications, including nephropathy, cardiovascular disease,
neuropathy and retinopathy [1]. Although diabetes-related eye
diseases are generally linked to hyperglycemia [2], iatrogenic
hypoglycemia causes morbidity in most people with type I diabetes
and in many with advanced type II diabetes [3]. Diabetic
retinopathy is the results of microvascular retinal changes
promoted by hyperglycemia through the formation of advanced
glycation end products, resulting in weakening and blockage of
blood vessels through up-regulation and secretion of vascular
endothelium growth factor (VEGF) [1,4]. The role of hypergly-
cemia in the retina via pericyte apoptosis and in vascular
complications has been extensively studied in a large number of
in vivo and/or ex vivo models [5,6].
While hyperglycemia is an accepted and well-investigated cause
of diabetes-related eye diseases, few studies exist which implicate
hypoglycemia as a key factor involved in visual disorders. The
majority of data has focused on in vitro or ex vivo studies: Luo et al.
showed that conditions of low glucose reduced viability of all
retinal cell types in a mixed primary cell culture [7] and Zeevalk
and Nicklas demonstrated the sensitivity of isolated chick retinas to
in vitro aglycemic conditions [8]. More recently, Umino et al.
showed that chronic moderate hypoglycemia in mouse led to loss
of vision and eventual retinal degeneration [9], while Punzo et al.
suggested that cone death in retinitis pigmentosa could be, at least
in part, the result of the starvation of cones via the insulin/mTOR
pathway [10].
Glutathione (c-L-glutamyl-L-cystein-glycine; GSH) is the most
abundant non-protein thiol in the cell. It is involved in many
cellular functions including regulation of DNA and protein
synthesis, signal transduction, cell cycle regulation, as well as
maintaining a stable thiol redox state by acting as an antioxidant
and scavenger [11]. They are few cellular mechanisms that control
intracellular levels of GSH (the reduced glutathione). Depletion of
GSH occurs essentially in a reaction in which glutathione
peroxidase (Gpx; E.C.1.11.1.9) reduces H2O2 by producing GSSG
(the oxidized glutathione) and H2O, while NADPH is used to
reduce back GSSG to GSH with the help of glutathione reductase
(GR; E.C.1.8.1.9). Glutathione transferase (Gst; E.C.2.5.1.18)
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targeting them for export from the cell. ‘‘Lost’’ GSH is replaced by
direct uptake of GSH or by ‘‘de novo’’ synthesis through a two-step
reaction utilizing L-glutamate, L-cysteine, glycine, ATP and both
glutamate-cysteine ligase (GCL; E.C.6.3.2.2) and glutathione
synthase (GS, E.C.6.3.2.3) (for review see [11,12]).
Cell death, e.g. apoptosis and necrosis, is in constant balance
with survival processes. Cells developed these signaling pathways
in response to extra- or intracellular stresses, such as UV
irradiation, starvation, growth factor deprivation, ER stress or
pathogen infection. First, affected cells react by up-regulating
genes implicated in cellular energy homeostasis and by adapting to
the environmental stress. Then, cell death occurs through
apoptosis or necrosis, two mechanisms leading to an irrevocable
killing. The two main pathways of apoptosis are extrinsic and
intrinsic as well as a perforin/granzyme pathway which, in turn,
will activate caspase-3 [13]. In addition, caspase-independent
mechanisms of neuronal cell death have also been identified.
We showed herein for the first time that acute insulin-induced
hypoglycemia led to retinal cell death via an activation of caspase 3
pathway and a decrease of GSH content. We confirmed these
results in photoreceptor 661W cells cultured at low glucose
condition. In addition, replenishment of GSH, by addition of
external glutathione ethyl ester protects the cells from low glucose-
induced apoptosis, while a decrease of GSH content by inhibition
of glutathione synthase at high glucose induced apoptosis. This
study suggests that a strict control of the glycemia is critical for
diabetic patients not only for brain defect but also for the
maintenance of a good retinal function and vision and that
glycemic excursion may not be harmless.
Methods
Mouse line
This study adhered to the Association for Research in Vision
and Ophthalmology (ARVO) statement for the use of animals in
ophthalmic and vision research and was approved by the
Veterinary service of the State of Valais, Switzerland (permit ID:
VS22). Wild-type 2-month-old C57BL/6 female mice (wt) were
purchased from Charles River Laboratories (Les Oncins, France).
Animals were kept in a 12-h light/12-h dark cycle with unlimited
access to food and water.
Hyperinsulinemic clamps
An indwelling catheter (Becton Dickinson AG, Basel, Switzer-
land) was inserted in the femoral vein of isoflurane-anesthetized
mice, which were allowed to recover for 4 to 7 days. After a 5-h
fasting period, awake and freely moving mice were subjected to
5 h of either a hyperinsulinemic/hypoglycemic or hyperinsulin-
emic/euglycemic clamp as described [14]. Mice were killed 4, 12
and 48 h post-clamp and isolated retinas were used to prepare
retinal flat mounts, mRNAs and proteins for analysis.
Cell Culture Conditions
Retinal explants were isolated from 2-month-old mice and
cultured, on a nitrocellulose filter (Millicell, Millipore AG,
Switzerland), in Dulbecco’s modified Eagle’s medium supplement-
ed with 10% heat-inactivated fetal calf serum (both from Sigma)
and 1% penicillin/streptomycin, for one-day prior to the
experiment. Then, retinal explants were cultured in glucose-free
DMEM supplemented with various glucose concentrations to
achieve low (2 mM) or high (25 mM) glucose. Human retinal
pigment epithelial cell line ARPE19 [15], 661W photoreceptor cell
line [16] and human adult Mu ¨ller glial cell line Mio-M1 [17] were
cultured as described in their respective publications except for
experiments at low and high glucose where cells were culture in
glucose-free DMEM supplemented with various glucose concen-
tration. One day before the experiment cells were synchronized
with 2% FCS in complete high glucose (25 mM) medium for 24 h.
Then, cells were cultured as indicated with various concentrations
of glucose during diverse periods of time prior to analysis. Caspase
3 inhibitor Z-VAD-FMK was added at 10 mM for 48 h at 2 mM
glucose before testing Caspase 3 activity and apoptosis by TUNEL
assay. To modulate GSH level we cultured 661W photoreceptor
cells at low (2 mM) or high (25 mM) glucose in absence or in
presence of 200 mM buthionine sulphoximine (BSO) or 1 mM
glutathione ethyl ester (GSHee) for 24 hours, then we analyzed for
GSH level and cell apoptosis.
Terminal dUTP Nick End-Labeling (TUNEL) of fragmented
DNA
In situ cell death detection was performed 24 or 48 h after low
glucose exposure, by TUNEL technology as described by the
manufacturer (Roche Applied Science, Rotkreus, Switzerland) and
detailed in Hamann S. et al. [18]. For each condition, apoptotic
cells were visualized under a fluorescence microscope (Olympus
BX51) using appropriate filters. Similar protocol was used on
mouse flat-mounted retinas isolated 48 h after the clamp.
Colorimetric TUNEL assay (Promega, Madison, WI, USA) was
used on ten mm-embedded frozen sections of enucleated eyes,
isolated from treated and control animals.
FACS analysis
Relative cell death and apoptosis were assessed by staining with
AnnexinV-FITC (IQ Products, Groningen, The Netherlands) and
7-AAD (Biolegend, San Diego, CA, USA) following the manufac-
turer’s protocol. Samples were loaded on a FACScan (Becton
Dickinson, San Jose, CA, USA) and analyzed with CellQuest
(Becton Dickinson) or FlowJo (Treestar) software.
Immunostaining
Enucleated eyes were fixed in 4% PFA/PBS for 45 min,
followed by cryoprotection in 30% sucrose/PBS. Ten mm-
embedded frozen sections were further processed for immunohis-
tochemistry. Briefly, frozen retina sections were blocked in PBS
with 3% normal goat serum (Sigma, Buchs, Switzerland) and 0.2%
Triton X-100 (Sigma) for 1 h at RT and incubated with an
antibody against cleaved Caspase 3 (dilution 1:500, Cell Signaling
Technology, Inc. Danvers, MA, USA) in the blocking buffer
overnight at 4uC. Sections were incubated again in blocking buffer
for 30 min at RT before being incubated with FITC Alexa-Fluor
594 goat anti-rabbit antibody (dilution 1/29000) for 1 h at RT.
Incubation with secondary antibody alone was used as a negative
control. Tissue sections were counterstained with DAPI to identify
retinal cell layers. 661W cells were cultured as described above
and fixed in paraformaldehyde 4% during 45 min prior to be
permeabilized and stained as described above.
Western Blot Analysis
Thirty micrograms of proteins were electrically transferred to
PVDF filters and incubated with anti–HIF3a (Rockland Immu-
nochemicals Inc., PA, USA) and anti–tubulin (Sigma; St-Louis,
MO). Secondary antibody, anti-rabbit-HRP (Amersham Biosci-
ences; Otelfingen, Switzerland), was used to detect protein
expression. Immune complexes were detected by chemilumines-
cence using LumiGLO (Amersham Biosciences, Otelfingen,
Switzerland).
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Caspase 3 activity was measured with a luminescent Caspase-
Glo 3/7 kit (Promega, Madison, WI, USA) as described by the
manufacturer. For superoxide detection, we used the MitoSOX
TM
detection reagent (Invitrogen, Basel, Switzerland) following the
protocol described by the manufacturer. Briefly, we added 2.5 mM
of the dye to the cells after exposition to low (2 mM) or elevated
(25 mM) glucose concentration for various periods of time (2, 4, 24
and 48 h). Superoxide was then visualized under a confocal
fluorescent microscope (Zeiss LSM 510) using appropriate filters.
RT-PCR analysis
Eight hundred ng of total RNA in a 20 ml reaction were used for
cDNA synthesis using oligo (dT)18 according to the manufactur-
er’s procedure (First strand cDNA synthesis kit for RT-PCR,
Roche Applied Science, Rotkreuz, Switzerland). The equivalent of
2 to 20 ng original total RNA was used for quantitative PCR
amplification using the 2 x brilliant SYBR Green QPCR Master
Mix (Stratagene) and 0.5 mM forward and reverse primer pair,
designed to span an intron of the target gene. We used Quantitec
primer assay (Qiagen, Switzerland) for Nox2 qPCR analysis. Real-
time PCR was performed in multiple replicate in the
Mx3000PTM system (Stratagene) with the conditions described
in Table S1.
GSH and ATP analysis
Twenty mg of total protein lysates, isolated from the retina of
sham operated (Ctl), hypoglycemic (Hypo) and euglycemic (Eugly)
mice, sacrificed 48 h post-clamp, were used for the measurement
of GSH retinal content. 661W cells were cultured as described
above, and GSH content was measured with Bioxytech GSH/
GSSG-412 kit (#21040; OxisResearch, Beverly Hills, CA, USA)
accordingly to the protocol. ATP content was measured with a
luminescence assay kit (ATPLite, PerkinElmer-BioSignal, Mon-
treal, QC, Canada) as described by the manufacturer. Briefly, cells
were cultured in 96-well plate at various glucose concentrations for
24 h or at 2 mM glucose for different periods of time, then lysis
buffer containing substrate was added directly to the cell and
luminescence was measured on an EnVision multilabel reader
(PerkinElmer- BioSignal, Montreal, QC, Canada), after 30
minutes of incubation.
Statistical Analysis
All results were expressed as means 6 SEM of the indicated
number of experiments. Statistical significance was calculated with
the Student’s t test.
Results
Acute 5 hours hypoglycemia induced retinal cell death in
mouse
To analyze the effect of well-controled hypoglycemia on mouse
retina, we performed a hyperinsulinemic/hypoglycemic clamp
(Hypo) to induce a five-hour hypoglycemia in mouse. We used
sham-operated mice (Ctl) and mice treated with a hyperinsulin-
emic/euglycemic clamp (Eugly) as control groups. The latter
group of mice received comparable amounts of insulin but was
injected with glucose in order to maintain normal glycemia.
Comparison of these two groups allowed us to analyze the specific
effect of hypoglycemia. We monitored glycemia during the whole
clamp (Fig. 1A). Glucose infusion, necessary to maintain either the
hypoglycemia at 2.2 mM or the euglycemia at 6 mM, is shown in
figure 1B. Body weight and glycemia before the clamp were
similar for both groups (Fig. 1C), while a significant expected
difference in glycemia was observed during the clamp (6.0060.05
and 2.2460.06 for euglycemic and hypoglycemic mice, respec-
tively). We first isolated flat-mount retinas 48 h after the clamp,
and performed a TUNEL staining in each group. Figure 2A shows
TUNEL-positive cells in the retina from hypoglycemic mice. Very
few positive cells were observed in euglycemic (Fig. 2A) and
control sham-operated mice (data not shown). We quantified
apoptotic cells from three flat-mount retinas isolated from each
group and obtained 312656 TUNEL-positive cells after acute
hypoglycemia (Fig. 2B) while few positive cells (1566 for Eugly
and 664 for Ctl) were detected in the two control groups. The
majority of TUNEL positive cells were localized in the outer
nuclear layer (ONL) and ganglion cell layers (GCL), as observed
by confocal microscopy. To more precisely define which
compartment of the retina was affected, we performed TUNEL
assay on 10-mm-embedded frozen sections. Figure 2C shows two
TUNEL positive cells in the ONL of hypoglycemic retina, but we
also observed TUNEL positive cells in the GCL (data not shown).
Low glucose culture conditions induced 661W
photoreceptor cell death
To better characterize the retinal cell death induced by low
glucose, we cultured different types of retinal cells (transformed
Figure 1 Insulin-induced hypoglycemia in C57BL/6 mouse. A)
Graphic representation of plasma glucose levels; B) glucose infusion
rates during the hyperinsulinemic/hypoglycemic clamp (black circle)
and the control hyperinsulinemic/euglycemic clamp (white circle). C)
Mouse characteristics before and during the clamp.
doi:10.1371/journal.pone.0021586.g001
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ARPE19 and Mu ¨ller cells: Mio-M1) at low glucose conditions
(2 mM) for various periods of time or for 24 h at diverse glucose
concentrations (Fig. 3A). While the ATP content did not change at
low glucose concentrations in ARPE19 and Mio-M1 cells (Fig. 3A),
we observed a dose- and time-dependent decrease of the ATP
content in the 661W cell line cultured at low glucose. TUNEL
assay performed on 661W cells showed a time dependant effect of
low glucose on cell death (Fig. 3B).
We then cultured these cells at low glucose concentration for
24 h and measured cell death by fluorescein isothiocyanate
(FITC)-conjugated AnnexinV and 7-Aminoactinomycin D (7-
AAD) labeling. Cells undergoing apoptosis exhibited disorganiza-
tion of the plasma membrane, followed by the externalization of
certain phospholipids such as phosphatidyl serine. AnnexinV-
positive and 7-AAD-negative cells showed early stage of apoptosis,
whereas cells positive for both 7-AAD and AnnexinV showed
necrotic or late apoptosis due to compromised plasma membrane
permeability (Fig. 3C). We could also observe late apoptosis
occurring after 24 h in cells exposed to low glucose concentration.
Low glucose-induced retinal cell death was a Caspase 3
dependent process
As apoptosis is often associated with caspase 3 activity, we tested
the activation of this enzyme in the retina of hypoglycemic and
euglycemic mice. We isolated whole eyes and fixed them prior to
analysis for cleaved caspase 3. Figure 4A shows positive cells in the
ONL and GCL of hypoglycemic mice, while no positive cells for
cleaved caspase 3 were observed in the retina of euglycemic mice.
Similar results were observed in vitro when photoreceptor 661W
cells were cultured for 24 h at low glucose (2 mM) concentration
(Fig. 4B). Caspase 3 activity induced by low glucose was time-
Figure 2. Acute hypoglycemia induced cell death in mouse retina. A) Flat-mounted retinas were isolated 48 h after the clamp, stained for cell
death by TUNEL assay and DAPI counter coloration was performed. White arrows show TUNEL positive cells in hypoglycemic condition. B)
Quantification of TUNEL positive cells was performed under a fluorescence microscope on retinal flat-mounts. Results are expressed as mean 6 SEM
of 3 different retinas for each group, * p,0.006 Hypo vs. Eugly. C) Ten mm-embedded frozen sections of enucleated eyes isolated from control (Ctl),
hypoglycemic (Hypo) and euglycemic (Eugly) animals were stained for cell death by colorimetric TUNEL system. Using this procedure, apoptotic
nuclei are stained dark brown (black arrow). A representative region of three different isolated retinas is shown.
doi:10.1371/journal.pone.0021586.g002
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48h, as measured by luminescent assay. We were able to observe
the induction of caspase 3 activity when the cells were serum
starved (SS) during 24 h as already described by Mackey et al. [19].
We then decided to confirm the role of Caspase 3 in low glucose-
induced 661W cell death, by testing the effect of an inhibitor.
Figure 4C showed that Z-VAD-FMK decreased Caspase 3 activity
by 70% and blocked 661W apoptosis, as assessed by TUNEL
analysis.
Low glucose induced mitochondrial superoxide
production
We then tested for low glucose induction of reactive species (RS)
as these compounds are regularly associated with programmed cell
death. We used the selective MitoSOX
TM red indicator to detect
superoxide production. Exposure of 661W photoreceptor cells to
low glucose concentration induced mitochondrial superoxide
production after 24 h that increased after 48 h (Fig. 5). Some
nuclei localization of fluorescent dye was also seen. This is most
likely due to the use of high concentration.
Reduced glutathione (GSH) content played key role in
cell death
Several recent studies implicated the GSH scavenger protein in
apoptotic processes [1,20,21]. To analyze in detail the key role of
GSH content in the process of cell death, we measured its
concentration in the retina of the three mouse groups. GSH
content was significantly decreased in hypoglycemic animals in
comparison with sham operated and euglycemic mice (Fig. 6A). A
similar result was observed in 661W cells with a 50% decrease of
GSH concentration 48 h after low glucose exposure (Fig. 6B).
Depletion of GSH content by inhibition of glutathione synthase
with buthionine sulphoximine (BSO) compound induced apoptosis
at 25 mM glucose, while restoration of GSH concentration to
‘‘normal’’ levels by adding external GSH (glutathione ethyl ester;
GSHee), at low glucose condition was accompanied by a blockage
of cell death (Fig. 6C).
To decipher which genes were involved in the low glucose-
induced cell death and GSH decrease, we tested the mRNA
expression of two enzymes playing a role in the GSH
homeostasis: the glutathione peroxidase 3 (Gpx3) functioning
in the detoxification of hydrogen peroxide and the glutathione
S-transferase omega 1 (Gsto1) serving a protective role by
adding GSH to proteins exported from the cell. We observed an
increased expression for both genes at 48 h by q-PCR analysis
(5 fold for Gpx3 and 2.2 fold for Gsto1) while no change in
mRNA expression was visible 4- and 12-h after the clamp
(Fig. 7A). Analysis of retinal explants showed that in vitro
exposure to low glucose (2 mM) for a 48-h period significantly
increased the expression of Gpx3 and Gsto1 to the same extent
as in vivo hypoglycemia (Fig. 7A). We then tested for the
expression of members of the peroxidase family in 661W cells
cultured at low glucose concentrations. While Gpx3 was not
expressed in those cells, expression of Gpx1 and Gpx4, two
Figure 3. Low glucose concentration induced 661W cell death. 661W, ARPE19 and Mio-M1 cells were cultured as mentioned in material &
methods, then A) cells were incubated at 2 mM glucose for different time periods or for 24 h at different glucose concentrations. ATP content was
measured and found decreased in 661W cells (white box) after exposure to low glucose concentrations while no change was observed for ARPE19
(gray box) and Mio-M1 cells (black box). Results are expressed as mean 6 SEM of 3 experiments, # p,0.05, * p,0.002 and ** p,0.0001 vs. control
(25 mM glucose or time 0). B) 661W cells were cultured as mentioned above, then cell death was analyzed by TUNEL assay, performed 24 or 48 h
after low glucose exposure followed by DAPI counter coloration. White arrows indicate TUNEL positive cells and condensed nuclei. TUNEL analysis
was representative of 3 distinct experiments. C) 661W cells were stained with AnnexinV-FITC and 7-AAD and analyzed by FACS after exposure to low
glucose for 24 h.
doi:10.1371/journal.pone.0021586.g003
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Gsto1 expression affected by low glucose condition in 661W
cells (Fig. 7B). However, we observed a down-regulation of the
expression of NADPH oxidase 4 (Nox 4), an enzyme involved in
the control of NADPH level and GSH homeostasis in the cell.
We also observed a slight, but not significant, increase of
NADPH oxidase 2 (Nox2) in both, the in vivo and in vitro
situations of low glucose (Figure S2).
Discussion
Glucose is essential for retinal function and glycemic excursions
may have harmful effects on vision. In diabetic patients,
deleterious effects of hyperglycemia have been well documented
and chronic hypoglycemia has been shown to affected retinal cells
in an animal model [9] and may induce cone cell death in retinitis
pigmentosa [10]. In general, type I diabetic patients suffer at least
Figure 4. Caspase 3 was activated in the retina of hypoglycemic mice and in 661W cells incubated at low glucose condition. A)
Immunohistological staining with cleaved Caspase 3 antibody showed positive cells (white arrow) in the outer nuclear (ONL) and ganglion cell layers
(GCL) of the hypoglycemic mice retina. Counterstaining with DAPI was performed to identify the retinal cell layers. Results were representative of
three observed retinas for each group. B) Similar immunostaining of cleaved Caspase 3 (white arrows) was performed on 661W cells, cultured during
48 h at 2 mM glucose and additional Caspase 3 activity was assessed in a time course at low glucose (2 mM) experiment, using a 24 h serum starved
(SS) cultured condition as positive control. Results are expressed as mean 6 SEM of 3 experiments, *p,0.006 and **p,0.0001 vs. Ctrl (time 0). C)
Measures of Caspase 3 activity in 661W cells cultured for 48 h at 2 mM glucose in absence or presence of Z-VAD-FMK inhibitor (10 mM). Results are
expressed as mean 6 SEM of 3 experiments, *p,0.0001. TUNEL assay was performed on similar conditions; white arrows indicated TUNEL positive
cells.
doi:10.1371/journal.pone.0021586.g004
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induced peroxide production was performed on 661W photoreceptor cells with the MitoSOX
TM dye. 661W cells were cultured at 25 mM and 2mM
glucose for diverse periods of time. Fluorescence intensity was visualized under a confocal microscope with appropriate filters.
doi:10.1371/journal.pone.0021586.g005
Figure 6. GSH content was decreased in low glucose conditions. A) GSH content was measured in protein lysates obtained from retina of
control (white circle), euglycemic (white triangle) and hypoglycemic (black square) mice. Results were expressed as percent of control and as mean 6
SEM of 5 to 7 samples. *p,0.025 vs. Eugly and **p,0.01 vs. Ctrl. B) 661W cells were cultured at low (2 mM) and high (25 mM) glucose conditions and
GSH content was measured at diverse periods of time. Results were expressed as mean 6 SEM of 3–5 experiments, *p,0.03 and **p,0.0002 vs.
25 mM glucose. C) GSH content was measured in 661W cells cultured for 48 h at 25 mM or 2 mM glucose, in absence or in presence of 200 mM
buthionine sulphoximine (BSO) or 1mM extracellular glutathione ethyl ester (GSHee). At the same time we measured cell death by TUNEL assay in
each condition. White arrows indicated TUNEL positive cells. Results are expressed as mean 6 SEM of 3 experiments; *p,0.003 vs. 2 mM glucose
without GSHee.
doi:10.1371/journal.pone.0021586.g006
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hypoglycemia, often with seizure or coma, per year [3].
In this study, we concentrated our investigation on acute
hypoglycemia, which is equivalent to severe hypoglycemia
occurring in patients, knowing that cerebral and retinal glucose
concentration approaches 0 mM when blood glucose concentra-
tion falls below 2 mM [22]. We showed that acute insulin-induced
hypoglycemia in mouse (blood glucose at 2.2 mM) led to retinal
apoptosis through the activation of caspase 3 and the modulation
of retinal GSH content. Despite positive cells for cleaved caspase3
were detected in retinas of hypoglycemic animals, further
experiments with caspase inhibitor will be necessary to clearly
implicate this enzyme in the apoptotic process observed in vivo. In
vitro experiments performed on 661W photoreceptor cells
confirmed both the activation of caspase 3 and the decrease of
GSH; additionally we were able to show mitochondrial superoxide
production.
Increased production of mitochondrial reactive species (RS) by
hyperglycemia is recognized as a major cause of the clinical
complications associated with diabetes and obesity. This produc-
tion is otherwise linked to a down-regulation of the GSH pool, via
activation of aldolase [1], and to the activation of caspase 3,
leading to neuronal dysfunction through N-methyl-D-aspartate
(NMDA) receptors [23]. It is interesting to notice that we
observed, in addition to GSH down regulation and caspase 3
activation, a production of mitochondrial superoxide. These
results are supported by several studies showing an increase of
superoxide production on hippocampal neurons cultured under
hypoglycemic conditions [24] and in neurons after glucose
deprivation [25]. Moreover, in vivo studies recently showed
production of mitochondrial RS in newborn brain during acute
hypoglycemia [26] and in insulin-induced hypoglycemic stress in
healthy subject [27].
Our results suggest that GSH level is a key player in retinal
apoptosis at least in 661W cells, as a decrease of GSH either by
low glucose or by BSO treatment correlated with cell death; while
replenishment of GSH blocked the apoptotic process. Further in
vivo experiments will be needed to clearly demonstrate the
implication of GSH decrease in cell death in hypoglycemic
conditions. The low glucose-induced GSH decrease is supported
by the work of Winkler et al. who observed a similar decrease when
they studied the effect of diamide oxidant on isolated rat retina
[28]. Interestingly, a decrease of GSH level was also observed in
the retina of streptozotocin-induced diabetic mice [29] and rats
[30], and restored by an over-expression of the antioxydant
mitochondrial superoxide dismutase (MnSOD) protein [29].
GSH is the predominant cellular non-protein thiol and is
usually up-regulated as an adaptative response to oxidative stress
in order to maintain a stable redox status. The key role of this
tripeptide may be more relevant in the retina, because of the high
oxidative metabolic activity occurring in this tissue. In addition,
GSH is involved in many cellular functions including apoptosis
[11,12]. On the one hand, it has been shown that GSH depletion
due to buthionine sulphoximine (BSO)-induced inhibition of GSH
synthesis, sensitizes cells to hyperoxia and H2O2 [21] or leads to
genome rearrangement [31]. On the other hand, addition of
extracellular glutathione ethyl ester (GSHee) to restore normal
GSH level, or the use of non-toxic analogue of cysteine, N-acetyl
Figure 7. Expression of enzymes implicated in GSH homeostasis was modulated by glucose concentration. A) We tested the
expression of two genes, Gpx3 and Gsto1, in the retina of hypoglycemic and euglycemic animals 48 h after the clamp. We were able to show, by RT-
qPCR, the induction of both genes in hypoglycemic conditions. In addition, we incubated retinal explants isolated from C57bl/6 mice for 48 h at low
(2 mM) and high (25 mM) glucose conditions and measured Gpx3 and Gsto1 expression in the whole retina. RL8 (ribosomal protein L8) was used as
internal control to normalize RNA expression and results are expressed as mean 6 SEM of 3 (4 and 12 h) to 8 (48 h) retinas, *p,0.03 and as mean 6
SEM of 4 to 6 isolated retina **p,0.02 vs. 25 mM glucose. B) We tested by RT-qPCR the expression of Gpx1, Gpx4, Gsto1 and Nox4 in 661W cells after
incubation for diverse periods of time (4, 12 and 48 h) at low (2 mM) and high (25 mM) glucose conditions. RL8 was used as internal control to
normalize RNA expression and results are expressed as mean 6 SEM of 3 experiments in triplicate.
doi:10.1371/journal.pone.0021586.g007
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oxidative damage [31] and prevents retinal photooxidative
damage induced by intense light [32].
How is the GSH cell content decreased in low glucose
conditions? In mouse, hypoglycemia induced up-regulation of
Gpx3 and Gsto1, which may partially explain the 40% decrease of
retinal GSH scavenger seen in our experiments. We observed a
large increase of Gpx3 mRNA expression in the retina of
hypoglycemic animals and our results are in accordance with a
recent study published by Miranda et al. showing an inhibitory
effect of glucose on Gpx activity, in vitro but also in alloxan-induced
diabetic animals [33]. Further promoter analyses will be necessary
to confirm and define more precisely the sequence responsible for
the transcriptional effect of glucose on Gpx3 promoter. We also
observed an increase of Gsto1 expression in hypoglycemic mice,
but no clear glucose-induced modulation of glutathione transferase
has been described in the literature. A recent study showed that
Gsto1 overexpression protects Hela cells against cisplatin-induced
apoptosis [34]. Yet, this enzyme is able to modify protein function
via s-glutathionylation, a process critical for preventing irreversible
oxidation of proteins [35] and therefore might prevent low
glucose-induced apoptosis. The use of thiol groups either by this
latter mechanism of glutathionylation or by peroxidation of RS
leads to a decrease of GSH pool. Normally, both reactions are
necessary to counteract oxidative stress induced by low glucose in
the retina. Further experiments by analyzing 8-hydroxyguanosine
(8-OHdG) production, resulting from oxidative DNA damage,
directly in the retina of hypoglycemic mouse, will be necessary to
challenge low glucose induction of superoxide in vivo. Furthermore,
the decrease of GSH content could be the result of a down-
regulation of GSH synthesis. These ATP-dependent reactions
could be altered in hypoglycemic (low ATP) conditions and/or
changed because of a decrease in the glutamate or cysteine cell
content, which are modulated by glucose [35]. Moreover,
glutamate uptake is an active ATP-dependent process and the
rate of glutamate refilling into the vesicles is reduced in the
absence of glucose [36].
The decrease of cellular GSH content observed in the 661W
cells is more difficult to explain because it was not dependent on
Gpx3, which we found not to be expressed in these cells. We tested
other members of the peroxidases family, i.e. Gpx1 and Gpx4 that
were described to protect retina against oxidative damage [20],
but could not observe any modification of their expression. Gsto1
was most likely not involved, as its expression was not modified by
low glucose exposure. The decrease of Keap1 and Nrf2 (Figure
S1C) may possibly explain GSH depletion, because many genes
involved in GSH synthesis (eg. glutamate cysteine ligase (GCL),
glutathione synthase (GS) and glutathione reductase (GR)) are
regulated by Nrf2 nuclear factor ([37,38]). On the other hand, we
did not observed any modification of expression of these two genes
in hypoglycemic animals (Figure S1A/S1B). Further analysis at
protein level will be necessary to detail the role of both
transcription factors in our hypoglycemic model.
Oxidation of NADPH to NADP
+ by producing H2O2 could
lead to an important reduction of GSSG back to GSH in presence
of GR. We observed a decrease of Nox4 expression and a slight,
but not significant, increase of Nox2 (Figure S2) in low glucose
condition. These results are not in accordance with previous
published studies showing an increase of neuronal NADPH
oxidase activity due to glucose reperfusion during a very-short
term hypoglycemia [39]. Both enzymes have been described to
contribute to 661W cell survival and a modification in their
expression could sensitize cells to apoptosis [40]. Change in
expression of NADPH oxidases would probably not clarify the
GSH reduction, but would explain cell death. However, absence
or reduction of glucose may lead to a decrease in multiple-
NADPH production pathways which might partially explain a
reduction of GSH [28]. It would be interesting to test if low
glucose could inhibit the pentose shuttle, decrease NADPH level
and thus, control GSH cell content. Further analysis will be
needed to decipher the specific role of NADPH oxidases (Nox 2
and Nox4) in the mechanisms induced by low glucose in the 661W
photoreceptor cell line and in hypoglycemic animals.
We also tested protein expression of hypoxia-inducible factor
(HIF) 3 a, because it has been described as key regulator in glucose
metabolism [41]. Heidbreder et al. recently described an in vivo
induction of this gene by insulin-induced hypoglycemia and
glucoprivation. We did not observe any HIF3 a increase in our
hypoglycemic mouse model (Figure S3A), but control groups were
different. We used a hyperinsulinemic/euglycemic clamp, while
Heidbreder et al. used saline injected animals as control in
comparison to hyperinsulinemic/hypoglycemic clamp and insulin
injected, respectively. This may explain the difference with our
results and justify further analysis. However, in low glucose
(2 mM) cultured 661W cells we observed an increase of HIF3 a
(Figure S3B), which is similar to Heidbreder’s observation in HT-
22 cells cultured at 5 mM [41]. We clearly need further studies to
implicate this protein in GSH depletion, ROS production and
caspase 3-induced apoptosis.
Our hypothesis is that sensitivity of retinal cells to stress (in our
case low glucose) is directly dependent on the GSH level. Enzymes
involved in GSH homeostasis try to counteract apoptosis by
adaptation to harmful environmental conditions. This leads to a
strong decrease of GSH that is deleterious for retinal cells.
Modulation of GSH/GSSG ratio is crucial to maintain normal
redox state and cell function. An increase of GSH will protect cells
against oxidative stress, while a low glucose-induced depletion of
GSH will induce an apoptotic process.
The key role of GSH in the retina is highlighted by the retinal
dystrophy observed in 2 sisters with GS deficiency [42]. In those
patients, the level of GSH content was 80% lower than in normal
subjects, and about 25% of patients affected by GSH deficiency
developed retinitis pigmentosa, retinal dystrophy, lens opacities or
decrease of visual acuity [43].
Many of the effects observed in our hypoglycemic conditions
were similar to those observed in hyperglycemic conditions [1].
These results strongly suggest that glycemic excursions may not be
harmless. A strict control of glycemia, to fence not only
hyperglycemia but also hypoglycemia, is critical for diabetic
patients for the maintenance of a good retinal function and vision.
Treatment of diabetic patients with antioxidant compounds may,
in addition, help to maintain stable redox within the cells and
reduce retinal cell death induced by hypoglycemia.
Supporting Information
Figure S1 Nrf2 and Keap1 expression after exposure to
low glucose. A) We tested the expression of Nrf2 and Keap1 in the
retina of hypoglycemic and euglycemic animals 48 h after the
clamp. We were not able to show any modification of gene
expression in hypoglycemic condition. Results are expressed as %
of control (Eugly) 6 SEM of 5 retinas. B) In addition, we obtained
similar results when we incubated retinal explants isolated from
C57bl/6 mice for 48 h at low (2 mM) and high (25 mM) glucose
conditions. RL8 was used as internal control to normalize RNA
expression and results are expressed as % of control (25 mM) 6
SEM of 8 retinas. C) We tested the expression of Nrf2 and Keap1 in
661W cells after incubation for diverse periods of time (8, 24 and
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was used as internal control to normalize RNA expression and
results are expressed as % of control (25 mM) 6 SEM of 2
experiments in triplicate, *p,0.0001.
(TIF)
Figure S2 Expression of Nox2 after exposure to low
glucose. A) We tested the expression of Nox2 in the retina of
hypoglycemic and euglycemic animals 48 h after the clamp. We
observed a small, not significant increase of gene expression in
hypoglycemic condition. RL8 was used as internal control to
normalize RNA expression and results are expressed as % of
control (Eugly) 6 SEM of 4 retinas. B) In addition, we obtained
similar results when we tested Nox2 expression in 661W cells
cultured at low (2 mM) and high (25 mM) glucose conditions for
various periods of time. RL8 was used as internal control to
normalize RNA expression and results are expressed as % of
control (25 mM) 6 SEM of 3 retinas.
(TIF)
Figure S3 HIF3 a protein expression in hypoglycemic
conditions. A) We tested the expression of HIF3 a in the retina
of hypoglycemic and euglycemic animals 48 h after the clamp and
found no variation in hypoglycemic condition. Tubulin was used
as internal control to normalize protein expression and results are
expressed as % of control (Eugly) 6 SEM of 4 retinas. B)W e
observed an increase of HIF3 a in photoreceptor 661W cells
cultured at low (2 mM) glucose condition for 48 hours. Tubulin
was used as internal control to normalize protein expression and
results are expressed as % of control (25 mM) 6 SEM of 5 retinas.
*p,0.002.
(TIF)
Table S1 qPCR conditions with primers.
(TIF)
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